U.S. Health and Human Services Secretary Xavier Becerra said on Friday the government will try to negotiate better prices for ...

Major updates include increasing vigilance related to antitrust and the DOJ’s blocking of UnitedHealth’s merger with Amedisys ...

The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a third more sales per ad dollar.

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A ...

As the J.P. Morgan Healthcare Conference enters its second day, we're tracking presentations from GSK, Novartis, Sanofi, Eli ...

Regeneron Pharmaceuticals, Inc. REGN provided business and pipeline updates at the 43rd Annual J.P. Morgan Healthcare ...

The health data company, based in Bellevue, Washington, plans to collect leftover specimens from consenting patients who get routine health care at participating facilities, Stat reported. Also in the ...

Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...

Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance rangeExciting development-stage pipeline with ...

Heading into one of the year’s JP Morgan Healthcare Conference, scheduled for Jan. 13-16, Massachusetts biotech leaders are ...